| Bioactivity | α-Amylase/α-Glucosidase-IN-5 (compound 4l) is a dual inhibitor of α-glucosidase (Glucosidase) and α-amylase (Amylases) with IC50s of 5.96 μM and 1.62 μM, respectively. α-Amylase/α-Glucosidase-IN-4 has potential antidiabetic activity[1]. |
| Target | IC50: 5.96 μM (α-Glucosidase), 1.62 μM (α-Amylases) |
| Name | α-Amylase/α-Glucosidase-IN-5 |
| Formula | C30H27BrN3O3P |
| Molar Mass | 588.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zareei S, et al. Discovery of novel 4,5-diphenyl-imidazol-α-aminophosphonate hybrids as promising anti-diabetic agents: Design, synthesis, in vitro, and in silico enzymatic studies. Bioorg Chem. 2023 Sep 9;141:106846.. . |
α-Amylase/α-Glucosidase-IN-5
CAS: F: C30H27BrN3O3P W: 588.43
α-Amylase/α-Glucosidase-IN-5 (compound 4l) is a dual inhibitor of α-glucosidase (Glucosidase) and α-amylase (Amylase
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.